Uganda National Tb And Leprosy Control Program' title='Uganda National Tb And Leprosy Control Program' />Original Article. A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control. Gavin J. Churchyard, M. Zx Printer Service Manual. B., B. Ch., Ph. D., Katherine L. Fielding, Ph. D., James. Faculty MRL Colorado State University. Dr. Henao Tamayo received her Medical Degree from the University of Antioquia, Colombia. After finishing medical school, she joined a research group investigating genetic characteristics that could predispose to tuberculosis TB. After that initial contact with basic research on a devastating global disease, she was determined to pursue a career in the field of TB. Partners. Through PS Kenya, we work closely with private sector stakeholders including more than 55 commercial distributors, 700 wholesalers, and more than 30,000. About one third of the world population has latent M. This review explains the approach to patients with latent infection, including an update. The leading humanitarian information source on global crises and disasters. Reliable and timely information from trusted sources. MSN Health and Fitness has fitness, nutrition and medical information for men and women that will help you get active, eat right and improve your overall wellbeing. Marcela obtained a Masters degree in Biomedical Sciences, with an emphasis on TB. During that time in Colombia she met professors from Colorado State University and came to CSU as a visiting scientist. She was later awarded a Ph. D by this institution, where she studied the cellular immune response to M. Currently she is an Assistant Professor at Department of Microbiology, Immunology Pathology, College of Veterinary Medicine and Biomedical Sciences, and the Co Director of CSU Flow Cytometry Facility. Dr. Henao Tamayo is interested in the immunopathogenesis of Tuberculosis. Using animal models, she evaluates the role of different types of T cells and Myeloid Derived cells in tuberculosis and BCG vaccination Bacille Calmette Guerin, the only approved vaccine against TB. She has tested numerous vaccine candidates evaluating the immune response they elicit in association with protection against tuberculosis disease. In the field of tuberculosis pathogenesis, her work has recently focused on evaluating murine models that develop necrotic granulomas in response to M. These models are more akin to human pathology, thus they are a great tool to evaluate antibiotic and vaccine efficacy, as well as to identify pathogenesis mechanisms. Based on the immunopathogenesis of the disease she is currently evaluating immunotherapeutic approaches that combined with chemotherapy could improve the treatment of tuberculosis. During the more than 1. Flow Cytometry as valuable tool in her studies, and in 2. Dr. Henao Tamayo and Dr. Allan, received an Emerging Innovations Facilities award from the Vice President of Research at CSU to create a distributed, campus wide flow cytometry core facility.